Haeng R. Seo

Gyeonggi-do, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Corrigendum to "ABRL8301, a novel 2-methoxyestradiol derivative, mitigates progressive pulmonary fibrosis by downregulating 11β-hydroxysteroid dehydrogenase 1" [Eur. J. Pharmacol. 1032 (2026) 179224].

Corrigendum to "ABRL8301, a novel 2-methoxyestradiol derivative, mitigates progressive pulmonary fibrosis by downregulating 11β-hydroxysteroid dehydrogenase 1" [Eur. J. Pharmacol. 1032 (2026) 179224].

Journal: European journal of pharmacology

Published: August 31, 2026

GRP78/BiP as a novel midbody component induces mitotic exit failure via PLK1 stabilization in hepatocellular carcinoma.

GRP78/BiP as a novel midbody component induces mitotic exit failure via PLK1 stabilization in hepatocellular carcinoma.

Journal: BMB reports

Published: July 24, 2026

ABRL8301, a Novel 2-Methoxyestradiol Derivative, Mitigates Progressive Pulmonary Fibrosis by Downregulating 11β-Hydroxysteroid Dehydrogenase 1.

ABRL8301, a Novel 2-Methoxyestradiol Derivative, Mitigates Progressive Pulmonary Fibrosis by Downregulating 11β-Hydroxysteroid Dehydrogenase 1.

Journal: European journal of pharmacology

Published: February 09, 2026

Erratum: Combined HIF-1α blockade and CHIR99021 treatment reverses pulmonary fibrosis via modulation endothelial-to-mesenchymal transition.

Erratum: Combined HIF-1α blockade and CHIR99021 treatment reverses pulmonary fibrosis via modulation endothelial-to-mesenchymal transition.

Journal: iScience

Published: February 02, 2026

HO-1197 as a Multifaceted Therapeutic: Targeting the Cell Cycle, Angiogenesis, Metastasis, and Tumor Immunity in Hepatocellular Carcinoma.

HO-1197 as a Multifaceted Therapeutic: Targeting the Cell Cycle, Angiogenesis, Metastasis, and Tumor Immunity in Hepatocellular Carcinoma.

Journal: International journal of molecular sciences

Published: August 20, 2025

Combined HIF-1α blockade and CHIR99021 treatment reverses pulmonary fibrosis via modulation endothelial-to-mesenchymal transition.

Combined HIF-1α blockade and CHIR99021 treatment reverses pulmonary fibrosis via modulation endothelial-to-mesenchymal transition.

Journal: iScience

Published: April 28, 2025

N-phenylquinazolin-4-amine-based EGFR TKIs suppress pulmonary fibrosis by modulating the EGFR/ERBB3 axis in epithelial-macrophage interaction.

N-phenylquinazolin-4-amine-based EGFR TKIs suppress pulmonary fibrosis by modulating the EGFR/ERBB3 axis in epithelial-macrophage interaction.

Journal: Communications biology

Published: January 31, 2025

Inhibition of 11β-hydroxysteroid dehydrogenase 1 alleviates pulmonary fibrosis through inhibition of endothelial-to-mesenchymal transition and M2 macrophage polarization by upregulating heme oxygenase-1.

Inhibition of 11β-hydroxysteroid dehydrogenase 1 alleviates pulmonary fibrosis through inhibition of endothelial-to-mesenchymal transition and M2 macrophage polarization by upregulating heme oxygenase-1.

Journal: Cell death & disease

Published: September 27, 2024

Human chemically-derived hepatic progenitors (hCdHs) as a source of liver organoid generation: Application in regenerative medicine, disease modeling, and toxicology testing.

Human chemically-derived hepatic progenitors (hCdHs) as a source of liver organoid generation: Application in regenerative medicine, disease modeling, and toxicology testing.

Journal: Biomaterials

Published: May 09, 2023

Inhibition of DNMT3B expression in activated hepatic stellate cells overcomes chemoresistance in the tumor microenvironment of hepatocellular carcinoma.

Inhibition of DNMT3B expression in activated hepatic stellate cells overcomes chemoresistance in the tumor microenvironment of hepatocellular carcinoma.

Journal: Scientific reports

Published: February 22, 2023

Deciphering the underlying mechanism of liver diseases through utilization of multicellular hepatic spheroid models.

Deciphering the underlying mechanism of liver diseases through utilization of multicellular hepatic spheroid models.

Journal: BMB reports

Published: January 20, 2023

HO-1089 and HO-1197, Novel Herbal Formulas, Have Antitumor Effects via Suppression of PLK1 (Polo-like Kinase 1) Expression in Hepatocellular Carcinoma.

HO-1089 and HO-1197, Novel Herbal Formulas, Have Antitumor Effects via Suppression of PLK1 (Polo-like Kinase 1) Expression in Hepatocellular Carcinoma.

Journal: Cancers

Published: December 15, 2022

Showing 1-12 of 40

Last Updated: 09/26/2026